News

2012

January 24, 2012
Precision Therapeutics Enhances Their Straightforward Approach to Personalizing Cancer Care

January 3, 2011
Sean McDonald handles growth and change at Precision Therapeutics, Inc.

2011

November 14, 2011
Precision Therapeutics Post

October 1, 2011
Sean McDonald Featured in Smart Business

September 21, 2011
Precision's Kord Kozma is one of Thirteen Human Resources Professionals Honored at Pittsburgh Business Time's 2011 HR Leadership Awards

September 8, 2011
See Precision's Profile on the Inc. 500/5000

September 7, 2011
Precision Therapeutics Presents Multi-Gene Breast Cancer Studies at 2011 Breast Cancer Symposium

August 26, 2011
Precision Therapeutics Inc. Prepares to Bring New Products to Markets

August 23, 2011
Precision Therapeutics Named on Inc. 500|5000 2011 List and Recognized for Achievements in Personalized Medicine Industry

July 6, 2011
Precision Therapeutics’ Largely Young Workforce is Helping Patients Fight Cancer with Individualized Drug Therapies in Directing Chemotherapy in Gynecologic Cancers

June 6, 2011
Precision Therapeutics Presents Clinical Study Emphasizing the Role of ChemoFx in Directing Chemotherapy in Gynecologic Cancers

June 6, 2011
Precision Therapeutics Demonstrates Utility of Multi-Gene Predictors in Predicting Chemotherapy Response for Breast Cancer Patients

June 1, 2011
Precision Therapeutics Post

May 6, 2011
Video (may take time to download): Precision Investor Bain Capital Ventures

April 27, 2011
Sean McDonald Interviewed on Health Talk Radio

April 18, 2011
Med Biogene Announces Closing of Partnership With Precision Therapeutics to Commercialize LungExpress DX

April 13, 2011
Precision Therapeutics' ChemoFx Demonstrates Significant Role In Selection of Chemotherapy Doublets In Non Small Cell Lung Cancer

April 7, 2011
Precision Therapeutics Announces New Tumor Profiling Product to Augment Utility of ChemoFx® and Further Personalize Cancer Treatment

April 2, 2011
Interview by WTAE Radio: The American Entrepreneur: How Precision Therapeutics Survived the Recession: A Conversation with CEO Sean McDonald and Ron Morris

March 19, 2011
Video: Sean McDonald Interviewed by Our Region's Business

March 1, 2011
Precision Therapeutics and Med BioGene Partner to Commercialize LungExpress DxTM

January 19, 2011
Precision Therapeutics Announces Two Pancreatic Cancer Studies Emphasizing the Utility of ChemoFx in Cancer Treatment Options

January 17, 2011
Precision Therapeutics Announces New Study on Multi-Gene Predictors at 2010 San Antonio Breast Cancer Symposium

2010

December 2, 2010
Precision Therapeutics To Present Abstracts At 33rd Annual San Antonio Breast Cancer Symposium

October 15, 2010
Precision Therapeutics President and CEO Sean McDonald Recognized as Pittsburgh Technology Council Tech 50 CEO of the Year

September 22, 2010
Precision Therapeutics President and CEO Sean McDonald Recognized as a Leading Business Executive and Recipient of 2010 Pacesetters Award

September 7, 2010
Precision Therapeutics Continues Dedicated Support to the NOCC 'Walk to Break the Silence'

September 2, 2010
Precision Therapeutics, Inc. Named to Pittsburgh Business Times 2010 Top 100

August 27, 2010
Precision Therapeutics Inc. Maintains Growth by Adopting Basic Business Concepts

August 26, 2010
Precision Makes List of Pittsburgh's Fastest Growing Companies

June 30, 2010
Precision Therapeutics Featured in Pop City News

June 30, 2010
Precision Therapeutics Growing Rapidly as it Augments Research and Development Efforts

June 16, 2010
Precision Therapeutics reels in $33M, hiring and opening a lab in the Chocolate Factory

June 11, 2010
Pittsburgh Business Times Article: Precision Therapeutics lands $33 million in venture capital

June 3, 2010
ChemoFx® Drug Response Marker Delivers Substantial Cost Savings

April 15, 2010
Precision Therapeutics to Present Abstracts at American Association for Cancer Research Meeting

March 2, 2010
Chemosensitivity/Resistance Assay Included As Part of the NCCN Principles of Chemotherapy

Feruary 3, 2010
Patients, Physicians Rely on ChemoFx® to Support Their Cancer Treatment Decisions

January 21, 2010
Precision Therapeutics CEO Presents at J.P. Morgan 28th Annual Healthcare Conference

January 21, 2010
Precision Therapeutics to Present at Jeffries 2010 Global Healthcare Services Conference